Showing 1 - 2 results of 2 for search 'Keegan Cooke', query time: 0.03s Refine Results
  1. 1
    1189 Elucidating the effects of chemotherapy and immune checkpoint blockade on the activity of tarlatamab, a DLL3-targeting bispecific T cell engager molecule, in small cell lung cancer preclinical models

    1189 Elucidating the effects of chemotherapy and immune checkpoint blockade on the activity of tarlatamab, a DLL3-targeting bispecific T cell engager molecule, in small cell lung c... by Keegan Cooke, Jinghui Zhan, Juan Estrada, Matthias Friedrich, Ran You, Petra Deegen, Julie M Bailis

    Published 2023-11-01
    Article
  2. 2
    627 The DLL3-targeted half-life extended bispecific T cell engager (HLE BiTE®) immune-oncology therapy AMG 757 has potent antitumor activity in neuroendocrine cancer

    627 The DLL3-targeted half-life extended bispecific T cell engager (HLE BiTE®) immune-oncology therapy AMG 757 has potent antitumor activity in neuroendocrine cancer by Keegan Cooke, Jinghui Zhan, Juan Estrada, Marie-Anne Damiette Smit, Aditya Shetty, Jonathan Werner, Fei Lee

    Published 2020-11-01
    Article

Search Tools: